TY - JOUR
T1 - Histological scoring for small lung adenocarcinomas 2 cm or less in diameter
T2 - A reliable prognostic indicator
AU - Maeshima, Akiko Miyagi
AU - Tochigi, Naobumi
AU - Yoshida, Akihiko
AU - Asamura, Hisao
AU - Tsuta, Koji
AU - Tsuda, Hitoshi
N1 - Funding Information:
Supported in part by the Grant-in-Aid for Cancer Research (16-1) from the Ministry of Health, Labor and Welfare.
PY - 2010/3
Y1 - 2010/3
N2 - Objective: Lung adenocarcinomas 2 cm or less in diameter were studied to develop histologic criteria predicting the outcome. MATERIALS and Methods: We reviewed 510 consecutive lung adenocarcinomas 2 cm or less in diameter and assessed three histologic parameters to implement a histologic scoring system: lymphovascular invasion, maximum diameter of the nonbronchioloalveolar carcinoma (BAC) component, and percentage of the solid, cribriform, and/or papillary component in the entire tumor volume (%solid/cribriform/papillary). One point was given to each of lymphovascular invasion-positive, non-BAC >10 mm and %solid/cribriform/papillary 30%, and by the sum of these points, a score of 0 to 3 was assigned for each tumor. We also evaluated minimally invasive adenocarcinomas comprising non-BAC 5 mm, Sakurai grades 1 and 2. Results: Five-year disease-free survival rates of 287 patients with a histologic score of 0, 69 with a score of 1, 64 with a score of 2, and 90 with a score of 3 were 98.9%, 92.4%, 78.4%, and 54.0%, respectively. The 510 tumors included 129 noninvasive and 127 minimally invasive adenocarcinomas. None of these tumors recurred. In remaining 254 patients with overtly invasive adenocarcinomas, 5-year disease-free survival rates in 51 with a histologic score of 0, 49 with a score of 1, 64 with a score of 2, and 90 with a score of 3 were 95.9%, 89.2%, 79.4%, and 54.2%, respectively. Conclusion: The histologic scoring system comprising lymphovascular invasion-positive, non-BAC >10 mm and %solid/cribriform/papillary 30% is able to predict the outcome of lung adenocarcinomas 2 cm or less in diameter not only in all cases but also in overtly invasive adenocarcinomas. Minimally invasive adenocarcinomas did not recur in this large series.
AB - Objective: Lung adenocarcinomas 2 cm or less in diameter were studied to develop histologic criteria predicting the outcome. MATERIALS and Methods: We reviewed 510 consecutive lung adenocarcinomas 2 cm or less in diameter and assessed three histologic parameters to implement a histologic scoring system: lymphovascular invasion, maximum diameter of the nonbronchioloalveolar carcinoma (BAC) component, and percentage of the solid, cribriform, and/or papillary component in the entire tumor volume (%solid/cribriform/papillary). One point was given to each of lymphovascular invasion-positive, non-BAC >10 mm and %solid/cribriform/papillary 30%, and by the sum of these points, a score of 0 to 3 was assigned for each tumor. We also evaluated minimally invasive adenocarcinomas comprising non-BAC 5 mm, Sakurai grades 1 and 2. Results: Five-year disease-free survival rates of 287 patients with a histologic score of 0, 69 with a score of 1, 64 with a score of 2, and 90 with a score of 3 were 98.9%, 92.4%, 78.4%, and 54.0%, respectively. The 510 tumors included 129 noninvasive and 127 minimally invasive adenocarcinomas. None of these tumors recurred. In remaining 254 patients with overtly invasive adenocarcinomas, 5-year disease-free survival rates in 51 with a histologic score of 0, 49 with a score of 1, 64 with a score of 2, and 90 with a score of 3 were 95.9%, 89.2%, 79.4%, and 54.2%, respectively. Conclusion: The histologic scoring system comprising lymphovascular invasion-positive, non-BAC >10 mm and %solid/cribriform/papillary 30% is able to predict the outcome of lung adenocarcinomas 2 cm or less in diameter not only in all cases but also in overtly invasive adenocarcinomas. Minimally invasive adenocarcinomas did not recur in this large series.
KW - %solid/cribriform/ papillary
KW - Lung
KW - Non-BAC size
KW - Scoring
KW - Small adenocarcinoma
KW - Vessel invasion
UR - http://www.scopus.com/inward/record.url?scp=77649331370&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77649331370&partnerID=8YFLogxK
U2 - 10.1097/JTO.0b013e3181c8cb95
DO - 10.1097/JTO.0b013e3181c8cb95
M3 - Article
C2 - 20125041
AN - SCOPUS:77649331370
SN - 1556-0864
VL - 5
SP - 333
EP - 339
JO - Journal of Thoracic Oncology
JF - Journal of Thoracic Oncology
IS - 3
ER -